Breaking News

BIA Separations and Labena Start Long Term Partnership

Labena will distribute BIA's products in Southeastern Europe

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BIA Separations, developer and manufacturer of convective interaction media (CIM) monolithic chromatographic columns and process development services, has formed a partnership with Labena, a provider of solutions for process and laboratory analytics in Southeastern Europe. “BIA Separations’ main focus has always been products for the manufacture of biological drugs, viral vectors and vaccines,” said Ales Strancar, chief executive officer, BIA Separations. “The gene therapy market started to g...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters